EUVIMEDEUVIMED entdecken
EvaluationsstudieOpen Access · CC BY 4.0

Evaluation of the efficacy of plan adaptation in stereotactic body proton therapy for pancreatic cancer

Yuto Matsuo, Yusuke Uchinami, Norio Katoh, Takayuki Hashimoto, Hidefumi Aoyama, Keiji Nakazato, Taeko Matsuura, Naoki Miyamoto, Seishin Takao

Journal of Applied Clinical Medical Physics · 2026

DOI: 10.1002/acm2.70644 ↗

Kurz gefasst

Evaluationsstudie in der Zeitschrift Journal of Applied Clinical Medical Physics, 2026. Verfasst von Yuto Matsuo und 8 weiteren Autor:innen. Beteiligte Einrichtung: Graduate School of Biomedical Science and Engineering, Hokkaido University, Sapporo, Japan. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Radiotherapy Planning, Computer-Assisted, Radiosurgery, Organs at Risk. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: JSPS KAKENHI.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

This study aimed to quantitatively evaluate the efficacy of plan adaptation in stereotactic body proton therapy (SBPT) for pancreatic cancer using daily CT‐based dose evaluation, investigate the appropriate adaptation frequency.

Methods

This retrospective planning study included 10 patients previously treated with X‐ray stereotactic body radiation therapy for pancreatic cancer. An initial SBPT plan was created for each patient, using robust optimization with two posterior oblique beams. The prescribed dose was D90 ≥ 40 Gy(RBE) to the CTV_EVAL (the CTV excluding the gastrointestinal [GI] tract plus a 5‐mm margin), delivered in five fractions. Daily dose evaluation (DDE) was performed using five daily CT (dCT) images per patient. An adaptive plan (AP) was generated and applied to subsequent fractions if target coverage or organs at‐risk (OARs) constraints were not met; otherwise, the initial plan (IP) was employed. Non‐adaptation (NA) and daily adaptation (DA) strategies were compared in terms of dose‐volume metrics, accumulated doses, tumor control probability (TCP), and normal tissue complication probability (NTCP).

Results

Across 50 fractions, plan adaptation was necessary in 21 fractions (42%), with a mean of 2.1 adaptations per patient. DA significantly improved target coverage on DDE compared with NA ( p < 0.05). Doses to the OARs, particularly the GI tract, were significantly reduced with DA. In the accumulated dose, DA led to a significantly higher D90 of CTV_EVAL ( p < 0.05), whereas doses to the OARs demonstrated no significant differences between strategies. TCP was significantly improved with DA, whereas NTCP demonstrated no significant differences for any OARs.

Conclusions

The DA strategy, according to DDE, improved target dose coverage while maintaining or reducing doses to the OARs. These findings indicate that appropriately frequent plan adaptation—an average of 2.1 adaptations per patient—may improve SBPT safety and efficacy for pancreatic cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pancreatic NeoplasmsRadiotherapy Planning, Computer-AssistedRadiosurgeryOrgans at RiskProton TherapyHumansRadiotherapy DosageRetrospective StudiesRadiotherapy, Intensity-ModulatedTomography, X-Ray ComputedPrognosisFemale

Stichwörter der Autor:innen

daily dose evaluationpancreatic cancerplan adaptationstereotactic body proton therapy

Autor:innen und Institutionen

  • Graduate School of Biomedical Science and Engineering, Hokkaido University, Sapporo, Japan.
  • Department of Medical Physics, Hokkaido University Hospital, Sapporo, Japan.
  • Department of Radiation Oncology, Hokkaido University Hospital, Sapporo, Japan.
  • Global Center for Biomedical Science and Engineering, Faculty for Medicine, Hokkaido University, Sapporo, Japan.
  • Department of Radiation Oncology, Faculty of Medicine, Hokkaido University, Sapporo, Japan.
  • Faculty of Engineering, Hokkaido University, Sapporo, Japan.

Förderung

  • JSPS KAKENHI

Zitieren

APA

Matsuo, Y., Uchinami, Y., Katoh, N., Hashimoto, T., Aoyama, H., Nakazato, K., Matsuura, T., Miyamoto, N., & Takao, S. (2026). Evaluation of the efficacy of plan adaptation in stereotactic body proton therapy for pancreatic cancer. Journal of Applied Clinical Medical Physics. https://doi.org/10.1002/acm2.70644

Vancouver

Matsuo Y, Uchinami Y, Katoh N, Hashimoto T, Aoyama H, Nakazato K, et al. Evaluation of the efficacy of plan adaptation in stereotactic body proton therapy for pancreatic cancer. Journal of Applied Clinical Medical Physics. 2026. doi:10.1002/acm2.70644

BibTeX
@article{Matsuo2026,
  author = {Matsuo, Yuto and Uchinami, Yusuke and Katoh, Norio and Hashimoto, Takayuki and Aoyama, Hidefumi and Nakazato, Keiji and Matsuura, Taeko and Miyamoto, Naoki and Takao, Seishin},
  title = {Evaluation of the efficacy of plan adaptation in stereotactic body proton therapy for pancreatic cancer},
  journal = {Journal of Applied Clinical Medical Physics},
  year = {2026},
  doi = {10.1002/acm2.70644}
}
Kostenlos starten →